This is a Validated Antibody Database (VAD) review about human SPINK1, based on 7 published articles (read how Labome selects the articles), using SPINK1 antibody in all methods. It is aimed to help Labome visitors find the most suited SPINK1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SPINK1 synonym: PCTT; PSTI; Spink3; TATI; TCP; serine protease inhibitor Kazal-type 1; pancreatic secretory trypsin inhibitor; serine protease inhibitor, Kazal type 1; tumor-associated trypsin inhibitor

Abnova
mouse monoclonal (4D4)
  • immunocytochemistry; human; loading ...; fig 1e
Abnova SPINK1 antibody (Abnova, H00006690-M01) was used in immunocytochemistry on human samples (fig 1e). Oncogenesis (2015) ncbi
mouse monoclonal (4D4)
  • immunohistochemistry; human; 1:50; loading ...; fig 1b
Abnova SPINK1 antibody (Abnova, H00006690-M01) was used in immunohistochemistry on human samples at 1:50 (fig 1b). PLoS ONE (2015) ncbi
mouse monoclonal (4D4)
  • western blot; human; 1:250; fig 2.d
Abnova SPINK1 antibody (Abnova, H00006690-M01) was used in western blot on human samples at 1:250 (fig 2.d). Nat Cell Biol (2015) ncbi
mouse monoclonal (4D4)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2b
Abnova SPINK1 antibody (Abnova, H00006690-M01) was used in immunohistochemistry - paraffin section on human samples (fig 2b). Prostate (2015) ncbi
mouse monoclonal (4D4)
  • immunocytochemistry; human
Abnova SPINK1 antibody (Abnova, H00006690-M01) was used in immunocytochemistry on human samples . Urol Oncol (2015) ncbi
mouse monoclonal (4D4)
  • immunohistochemistry - paraffin section; human; 1:100
Abnova SPINK1 antibody (Abnova, H00006690-M01) was used in immunohistochemistry - paraffin section on human samples at 1:100. Clin Cancer Res (2014) ncbi
R&D Systems
mouse monoclonal (839305)
  • western blot; human; loading ...; fig 1c
R&D Systems SPINK1 antibody (R&D, MAB7496) was used in western blot on human samples (fig 1c). Cancer Cell (2017) ncbi
Articles Reviewed
  1. Shukla S, Cyrta J, Murphy D, Walczak E, Ran L, Agrawal P, et al. Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. Cancer Cell. 2017;32:792-806.e7 pubmed publisher
  2. Tiwari R, Pandey S, Goel S, Bhatia V, Shukla S, Jing X, et al. SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression. Oncogenesis. 2015;4:e162 pubmed publisher
  3. Brooks J, Wei W, Hawley S, AUMAN H, Newcomb L, Boyer H, et al. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients. PLoS ONE. 2015;10:e0132343 pubmed publisher
  4. Laberge R, Sun Y, Orjalo A, Patil C, Freund A, Zhou L, et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol. 2015;17:1049-61 pubmed publisher
  5. Ateeq B, Kunju L, Carskadon S, Pandey S, Singh G, Pradeep I, et al. Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India. Prostate. 2015;75:1051-62 pubmed publisher
  6. Palanisamy N, Tsodikov A, Yan W, Suleman K, Rittmaster R, Lucia S, et al. Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trial. Urol Oncol. 2015;33:108.e5-13 pubmed publisher
  7. Flavin R, Pettersson A, Hendrickson W, Fiorentino M, Finn S, Kunz L, et al. SPINK1 protein expression and prostate cancer progression. Clin Cancer Res. 2014;20:4904-11 pubmed publisher